Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:MMSI
CUSIP58988910
Phone801-253-1600
Debt
Debt-to-Equity Ratio0.56
Current Ratio2.66
Quick Ratio1.45
Price-To-Earnings
Trailing P/E Ratio43.95
Forward P/E Ratio34.45
P/E Growth2.59
Sales & Book Value
Annual Sales$727.85 million
Price / Sales4.25
Cash Flow$2.4332 per share
Price / Cash23.22
Book Value$13.47 per share
Price / Book4.19
Profitability
EPS (Most Recent Fiscal Year)$1.28
Net Income$27.52 million
Net Margins2.44%
Return on Equity10.48%
Return on Assets6.05%
Miscellaneous
Employees4,876
Outstanding Shares54,740,000
Market Cap$3.00 billion
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its quarterly earnings results on Monday, July, 23rd. The medical instruments supplier reported $0.43 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.40 by $0.03. The medical instruments supplier had revenue of $224.81 million for the quarter, compared to analyst estimates of $214.64 million. Merit Medical Systems had a return on equity of 10.48% and a net margin of 2.44%. The company's quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.36 EPS. View Merit Medical Systems' Earnings History.
When is Merit Medical Systems' next earnings date?
What guidance has Merit Medical Systems issued on next quarter's earnings?
Merit Medical Systems issued an update on its FY18 earnings guidance on Monday, July, 23rd. The company provided EPS guidance of $1.60-1.70 for the period, compared to the Thomson Reuters consensus estimate of $1.65. The company issued revenue guidance of $870-880 million, compared to the consensus revenue estimate of $849.78 million.
What price target have analysts set for MMSI?
9 analysts have issued 12 month price objectives for Merit Medical Systems' shares. Their predictions range from $44.00 to $70.00. On average, they expect Merit Medical Systems' share price to reach $60.8750 in the next year. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.
Are investors shorting Merit Medical Systems?
Merit Medical Systems saw a increase in short interest in the month of July. As of July 13th, there was short interest totalling 2,533,280 shares, an increase of 33.0% from the June 29th total of 1,904,981 shares. Based on an average daily trading volume, of 349,645 shares, the short-interest ratio is presently 7.2 days. Currently, 5.2% of the shares of the stock are short sold. View Merit Medical Systems' Current Options Chain.
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Integra Lifesciences (IART), Haemonetics (HAE), Globus Medical (GMED), Insulet (PODD), Penumbra (PEN), Cantel Medical (CMD), Novocure (NVCR), NuVasive (NUVA), Irhythm Technologies (IRTC), Nevro (NVRO) and Tandem Diabetes Care (TNDM).
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 68)
- Mr. Ronald A. Frost, Chief Operating Officer (Age 56)
- Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 57)
- Mr. Joseph C. Wright, Pres of International Division (Age 48)
- Mr. Raul Parra, Interim Chief Financial Officer
Has Merit Medical Systems been receiving favorable news coverage?
Media headlines about MMSI stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Merit Medical Systems earned a media and rumor sentiment score of 0.11 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 45.59 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Merit Medical Systems.
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.88%), Dimensional Fund Advisors LP (4.09%), Eagle Asset Management Inc. (3.70%), Partner Fund Management L.P. (2.66%), Janus Henderson Group PLC (2.27%) and Macquarie Group Ltd. (1.97%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Institutional Ownership Trends for Merit Medical Systems.
Which institutional investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Aristotle Capital Boston LLC, Copper Rock Capital Partners LLC, OppenheimerFunds Inc., Royce & Associates LP, Dimensional Fund Advisors LP, Massachusetts Financial Services Co. MA, Mackay Shields LLC and Rothschild Asset Management Inc.. Company insiders that have sold Merit Medical Systems company stock in the last year include Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger and Michael E Stillabower. View Insider Buying and Selling for Merit Medical Systems.
Which institutional investors are buying Merit Medical Systems stock?
MMSI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Partner Fund Management L.P., Advisors Asset Management Inc., Frontier Capital Management Co. LLC, Redwood Investments LLC, Carillon Tower Advisers Inc., Wells Fargo & Company MN and Castleark Management LLC. View Insider Buying and Selling for Merit Medical Systems.
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $56.50.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $3.00 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
